ProQR Therapeutics NV (NASDAQ:PRQR)

BATS BZX Real-Time Price
As of 3:14pm ET
 -0.11 / -1.73%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for ProQR Therapeutics NV have a median target of 21.60, with a high estimate of 36.92 and a low estimate of 17.07. The median estimate represents a +245.00% increase from the last price of 6.26.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in ProQR Therapeutics NV. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 02

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 1.10%
Growthannually -0.79%


Growthquarterly 385.96%
Growthannually -15.25%
Key to the earnings and sales forecast charts.